• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Hepion Pharmaceuticals Inc (NQ: HEPA )

    0.7682 -0.0218 (-2.76%)
    Streaming Delayed Price Updated: 2:14 PM EDT, Jul 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 37,744
    Open 0.7600
    Bid (Size) 0.7700 (3)
    Ask (Size) 0.8000 (1)
    Prev. Close 0.7900
    Today's Range 0.7355 - 0.8247
    52wk Range 0.7301 - 8.313
    Shares Outstanding 5,472,451
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Fatty-Liver Focused Hepion Pharmaceuticals Agrees To Merge With Israel-Based Parkinson's Disease Drug Developer
    Hepion Pharmaceuticals announces merger with Pharma Two B Ltd., creating a combined company focused on Parkinson's disease treatment. The merger values Hepion at $58.5 million, and Pharma Two B plans... 
    Via Benzinga
    HEPA Stock Earnings: Hepion Pharmaceuticals Reported Results for Q1 2024
    Hepion Pharmaceuticals just reported results for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -75.61%
    -75.61%
    1 Month
    -28.21%
    -28.21%
    3 Month
    -43.93%
    -43.93%
    6 Month
    -58.25%
    -58.25%
    1 Year
    -90.34%
    -90.34%

    More News

    Read More
    S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
    Via Benzinga
    Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Gold Falls Sharply; Matterport Shares Spike Higher
    Via Benzinga
    Nike Layoffs 2024: What to Know About the Latest Nike Job Cuts
    Via InvestorPlace
    Topics Workforce
    Exposures Layoff
    Dow Jumps Over 100 Points; Chicago Fed National Activity Rises In March
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    HEPA Stock Earnings: Hepion Pharmaceuticals Beats EPS for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Over $18M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why Microvast Holdings Shares Are Trading Lower By Around 22%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Tesla, Zoom, Hepion, Pfizer, ZIM: Why These 5 Stocks Are Drawing Investor Attention Today
    Via Benzinga
    Hepion Pharmaceuticals (NASDAQ: HEPA) Reports Promising Phase 2 Trial Results for NASH Treatment
    Via Spotlight Growth
    Topics Death
    Exposures Death
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.